Employees: NN (None)Legal category: Société à responsabilité limitée (sans autre indication)Size: PMECreation date: 2014-12-15 (11 years)Status: ActiveBusiness sector: Location de terrains et d'autres biens immobiliersLocation: BEZIERS (34500), Herault
BALMAT POLE MEDICAL : revenue, balance sheet and financial ratios
BALMAT POLE MEDICAL is a French company
founded 11 years ago,
specialized in the sector Location de terrains et d'autres biens immobiliers.
Based in BEZIERS (34500),
this company of category PME
shows in 2021 a revenue of 7 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - BALMAT POLE MEDICAL (SIREN 808220099)
Indicator
2021
2020
2019
2018
2017
2016
2015
2014
Revenue
7 250 €
6 792 €
7 104 €
9 159 €
9 013 €
9 013 €
8 760 €
500 €
Net income
-3 501 €
-587 €
-712 €
1 119 €
1 645 €
517 €
1 639 €
-343 €
EBITDA
92 €
3 190 €
3 368 €
5 767 €
6 458 €
5 459 €
5 561 €
-309 €
Net margin
-48.3%
-8.6%
-10.0%
12.2%
18.3%
5.7%
18.7%
-68.6%
Revenue and income statement
In 2021, BALMAT POLE MEDICAL achieves revenue of 7 k€. Over the period 2014-2021, the company shows strong growth with a CAGR (compound annual growth rate) of +46.5%. Vs 2020: +7%. After deducting consumption (0 €), gross margin stands at 7 k€, i.e. a rate of 100%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 92 €, representing 1.3% of revenue. Warning negative scissor effect: despite revenue change (+7%), EBITDA varies by -97%, reducing margin by 45.7 pts. This reflects costs rising faster than revenue. The operating margin remains fragile, requiring cost vigilance. Net income is negative at -4 k€ (-48.3% of revenue), which will impact equity.
Revenue (2021)
?
Revenue
Definition
Total amount of sales of goods and services made by the company.
Formula
Sales of goods + Sold production
7 250 €
Gross margin (2021)
?
Gross margin
Definition
Difference between revenue and cost of goods sold.
Formula
Revenue - Cost of goods consumed
7 250 €
EBITDA (2021)
?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity
92 €
EBIT (2021)
?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals
-2 963 €
Net income (2021)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
-3 501 €
EBITDA margin (2021)
?
EBITDA margin
Definition
Measures the company's operating profitability.
Formula
(EBE / CA) x 100
Interpretation
> 10% : Good profitability 5-10% : Average < 5% : Low
1.3%
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 8758%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 93%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2021)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
8757.969%
Financial autonomy (2021)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
92.887%
Cash flow / Revenue (2021)
?
Cash flow / Revenue
Definition
Self-financing capacity relative to revenue.
Formula
(CAF / CA) x 100
Interpretation
The higher the ratio, the more cash the company generates
-6.152%
Repayment capacity (2021)
?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent 3-5 years : Fair > 5 years : Warning
-72.249
Asset age ratio (2021)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2014
2015
2016
2017
2018
2019
2020
2021
Debt ratio
111.111
4699.651
3530.857
2102.176
1552.717
1640.247
1709.21
8757.969
Financial autonomy
22.249
95.851
94.267
94.592
93.318
92.733
92.915
92.887
Repayment capacity
0.0
18.392
17.814
12.51
12.178
19.542
16.354
-72.249
Cash flow / Revenue
-61.6%
52.249%
47.232%
59.736%
52.67%
36.022%
37.029%
-6.152%
Sector positioning
Debt ratio
8757.972021
2019
2020
2021
Q1: -2.0
Med: 12.57
Q3: 178.71
Average
In 2021, the debt ratio of BALMAT POLE MEDICAL (8757.97) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
92.89%2021
2019
2020
2021
Q1: 2.35%
Med: 38.31%
Q3: 81.37%
Excellent
In 2021, the financial autonomy of BALMAT POLE MEDICAL (92.9%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
Repayment capacity
-72.25 years2021
2019
2020
2021
Q1: -0.0 years
Med: 0.54 years
Q3: 9.67 years
Excellent-50 pts over 3 years
In 2021, the repayment capacity of BALMAT POLE MEDICAL (-72.25) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 5.49. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 584.8x. Operating income very largely covers interest expenses: high safety margin.
Liquidity ratio (2021)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
5.489
Interest coverage (2021)
?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Formula
EBIT / Interest expenses
Interpretation
> 3 : Comfortable 1.5-3 : Acceptable < 1.5 : Risk
584.783
Liquidity indicators evolution BALMAT POLE MEDICAL
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2014
2015
2016
2017
2018
2019
2020
2021
Liquidity ratio
54.781
79.711
64.91
54.226
42.919
28.182
13.56
5.489
Interest coverage
0.0
17.695
22.0
16.615
16.334
24.02
21.16
584.783
Sector positioning
Liquidity ratio
5.492021
2019
2020
2021
Q1: 84.53
Med: 265.45
Q3: 1031.63
Watch
In 2021, the liquidity ratio of BALMAT POLE MEDICAL (5.49) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
Interest coverage
584.78x2021
2019
2020
2021
Q1: 0.0x
Med: 0.0x
Q3: 12.94x
Excellent
In 2021, the interest coverage of BALMAT POLE MEDICAL (584.8x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 0 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 184 days. Excellent situation: suppliers finance 184 days of the operating cycle (retail model). WCR is negative (-1894 days): operations structurally generate cash. Notable WCR improvement over the period (-1644%), freeing up cash.
Operating WCR (2021)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
-38 147 €
Customer credit (2021)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2021)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
184 j
Inventory turnover (2021)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR in days of revenue (2021)
?
WCR in days of revenue
Definition
Expresses working capital requirement in days of revenue.
Formula
(Operating WCR / Revenue) x 360
Interpretation
The fewer days, the better the working capital management
-1894 j
WCR and payment terms evolution BALMAT POLE MEDICAL
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2014
2015
2016
2017
2018
2019
2020
2021
Operating WCR
-2 187 €
-8 416 €
-26 577 €
-27 136 €
-26 349 €
-28 894 €
-31 153 €
-38 147 €
Inventory turnover (days)
0
0
0
0
0
0
0
0
Customer payment term (days)
0
0
0
0
0
0
0
0
Supplier payment term (days)
89
68
79
91
66
117
117
184
Positioning of BALMAT POLE MEDICAL in its sector
Comparison with sector Location de terrains et d'autres biens immobiliers
Valuation estimate
Based on 178 transactions of similar company sales
in 2021,
the value of BALMAT POLE MEDICAL is estimated at
2 173 €
(range 797€ - 5 457€).
With an EBITDA of 92€, the sector multiple of 4.7x is applied.
The price/revenue ratio is 0.70x
(in line with sector norms).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2021
178 transactions
0k€2k€5k€
2 173 €Range: 797€ - 5 457€
NAF 5 année 2021
Valuation detail by method
Ajustez les pondérations selon votre analyse
EBITDA Multiple50%
92 €×4.7x
Estimation436 €
212€ - 723€
Revenue Multiple30%
7 250 €×0.70x
Estimation5 070 €
1 774€ - 13 349€
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 178 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Location de terrains et d'autres biens immobiliers)
Compare BALMAT POLE MEDICAL with other companies in the same sector:
Frequently asked questions about BALMAT POLE MEDICAL
What is the revenue of BALMAT POLE MEDICAL ?
The revenue of BALMAT POLE MEDICAL in 2021 is 7 k€.
Is BALMAT POLE MEDICAL profitable?
BALMAT POLE MEDICAL recorded a net loss in 2021.
Where is the headquarters of BALMAT POLE MEDICAL ?
The headquarters of BALMAT POLE MEDICAL is located in BEZIERS (34500), in the department Herault.
Where to find the tax return of BALMAT POLE MEDICAL ?
The tax return of BALMAT POLE MEDICAL is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does BALMAT POLE MEDICAL operate?
BALMAT POLE MEDICAL operates in the sector Location de terrains et d'autres biens immobiliers (NAF code 68.20B). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart